David B Meya

Infectiology — Mulago Hospital, Uganda

LeadR Profile

David B Meya Mulago Hospital Uganda
1 393 ScienceLeadR Reputation 1393
Network Map

Infectiology

Subspecialties: Neurology - Public Health - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2007 - 2026

Source: PubMed

Makerere University

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Review of Risk Factors and Factors Influencing Outcomes of Cryptococcal Meningitis in Persons Living with HIV.
mortality, meningitis, meningitis, cryptococcal, risk factors, therapeutics
Infect Drug Resist20260
Concordance Between Fingerprick and Venous Whole Blood CD4 Counts Using the Visitect CD4 Advanced disease platform.
cd4 lymphocyte count, blood, communicable diseases
J Infect Dis20261
Once-Daily Dolutegravir-Based Antiretroviral Therapy Among Adults With Advanced HIV Disease Receiving 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis-Preventive Therapy and Fluconazole for Treatment of Cryptococcal Meningitis: Results of a Pharmacokinetic Study.
cd4 lymphocyte count, pharmaceutical preparations, fluconazole, meningitis, hiv, meningitis, cryptococcal, tuberculosis, therapeutics, isoniazid, plasma, pharmacokinetics, dolutegravir
Open Forum Infect Dis20260
Bilateral Pathological Femoral Fractures Secondary to Long-Term Tenofovir Disoproxil Fumarate-Induced Osteomalacia in a Woman Living with HIV: A Case Report.
tenofovir, alkaline phosphatase, osteomalacia, femoral fractures, hypophosphatemia, vitamins, pain, fumarates, phosphoric monoester hydrolases, therapeutics, fractures, spontaneous, abacavir
Int Med Case Rep J20261
How have global guidelines advanced the management of cryptococcosis in two years?
cryptococcosis
Expert Rev Anti Infect Ther20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

Phase 2 3
N/A 2
Phase 2/Phase 3 2
Phase 3 2
Phase 4 2
Phase 1/Phase 2 1

By status:

Completed 7
Recruiting 3
Not yet recruiting 1
Unknown 1

By type:

Interventional 11
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 7
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
B PaLMZ for TB Meningitis
NCT07227779 — moxifloxacin, tuberculosis, meningeal, latent tuberculosis, linezolid, meningitis, tuberculosis, therapeutics, pyrazinamide
Phase 2Recruiting2026
Platform Trial For Cryptococcal Meningitis (PLATFORM CM)
NCT06666322 — injections, mortality, pharmaceutical preparations, fluconazole, sterols, flucytosine, meningitis, acquired immunodeficiency syndrome, hiv, meningitis, cryptococcal, azoles, cryptococcus, amphotericin b, therapeutics, infections
Phase 2/Phase 3Recruiting2025
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3
NCT05541107 — meningitis, meningitis, cryptococcal, amphotericin b
Phase 3Not yet recruiting2023

LeadR Networks

Main global connection map